Investor Relations (IR) Questions: Durata Therapeutics DRTX
Click here to return to the biotech IRQ Index
Answers received: February 2013
1) When is the last time DRTX raised cash through an offering (diluted)?
Durata raised $74M in an IPO in July 2012.
2) How much cash (not cash equivalents) does DRTX have?
Latest public filing - Q3 – stated DRTX had $60.8M.
3) What and approximately when is the next known catalyst?
We anticipate reporting data from our second Phase 3 study in 1Q13.
4) What is DRTX's quarterly cash burn?
We do not disclose a burn rate.
5) Does DRTX have an existing line of credit and if so how much can they draw against it?
Durata does not have a line of credit.
1) When is the last time DRTX raised cash through an offering (diluted)?
Durata raised $74M in an IPO in July 2012.
2) How much cash (not cash equivalents) does DRTX have?
Latest public filing - Q3 – stated DRTX had $60.8M.
3) What and approximately when is the next known catalyst?
We anticipate reporting data from our second Phase 3 study in 1Q13.
4) What is DRTX's quarterly cash burn?
We do not disclose a burn rate.
5) Does DRTX have an existing line of credit and if so how much can they draw against it?
Durata does not have a line of credit.
